Verici Dx (LON:VRCI) Trading Down 12% – Here’s Why

Verici Dx plc (LON:VRCI)’s stock price traded down 12% on Thursday . The company traded as low as GBX 0.55 and last traded at GBX 0.55. 360,247 shares were traded during trading, a decline of 75% from the average session volume of 1,425,193 shares. The stock had previously closed at GBX 0.63.

Verici Dx Trading Down 5.6%

The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64. The business has a 50-day simple moving average of GBX 0.71 and a 200-day simple moving average of GBX 0.69. The company has a market cap of £8.93 million, a PE ratio of -0.20 and a beta of 1.59.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.